Loading...
Elite Pharmaceuticals, Inc.
ELTP•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.53
$0.01(1.92%)
Elite Pharmaceuticals, Inc. (ELTP) Financial Performance & Statements
Review Elite Pharmaceuticals, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-99.83%
↓ 99.83%
Operating Income Growth
-99.47%
↓ 99.47%
Net Income Growth
-99.54%
↓ 99.54%
Operating Cash Flow Growth
-198.29%
↓ 198.29%
Operating Margin
23.32%
↑ 23.32%
Gross Margin
47.70%
↑ 47.70%
Net Profit Margin
-5.13%
↓ 5.13%
ROE
-8.83%
↓ 8.83%
ROIC
23.18%
↑ 23.18%
Elite Pharmaceuticals, Inc. (ELTP) Financial Statements
Explore quarterly and annual reports for Elite Pharmaceuticals, Inc. stock.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $14.36M | $18.88M | $18.80M | $17.95M |
| Cost of Revenue | $8.24M | $10.68M | $10.33M | $10.21M |
| Gross Profit | $6.12M | $8.20M | $8.47M | $7.74M |
| Gross Profit Ratio | $0.43 | $0.43 | $0.45 | $0.43 |
| R&D Expenses | $1.79M | $1.97M | $2.16M | $1.72M |
| SG&A Expenses | $2.72M | $2.33M | $2.02M | $2.29M |
| Operating Expenses | $5.02M | $4.71M | $4.19M | $4.009M |
| Total Costs & Expenses | $13.27M | $15.40M | $14.94M | $14.22M |
| Interest Income | $5092.00 | $5902.00 | $5390.00 | $4833.00 |
| Interest Expense | $77607.00 | $255136.00 | $250781.00 | $217144.00 |
| Depreciation & Amortization | $489633.00 | $553466.00 | $558741.00 | $513802.00 |
| EBITDA | -$10.09M | -$8.71M | $1.66M | $4.06M |
| EBITDA Ratio | -$0.70 | -$0.46 | $0.09 | $0.23 |
| Operating Income | $1.10M | $3.48M | $3.86M | $3.73M |
| Operating Income Ratio | $0.08 | $0.18 | $0.21 | $0.21 |
| Other Income/Expenses (Net) | -$11.75M | -$13.004M | -$3.02M | -$1.74M |
| Income Before Tax | -$10.65M | -$9.52M | $847752.00 | $1.99M |
| Income Before Tax Ratio | -$0.74 | -$0.50 | $0.05 | $0.11 |
| Income Tax Expense | $239175.00 | $1.52M | $231979.00 | -$1.33M |
| Net Income | -$10.89M | -$11.04M | $615773.00 | $3.33M |
| Net Income Ratio | -$0.76 | -$0.58 | $0.03 | $0.19 |
| EPS | -$0.01 | -$0.01 | $0.001 | $0.003 |
| Diluted EPS | -$0.01 | -$0.01 | $0.001 | $0.003 |
| Weighted Avg Shares Outstanding | $1.07B | $1.07B | $1.07B | $1.02B |
| Weighted Avg Shares Outstanding (Diluted) | $1.07B | $1.07B | $1.08B | $1.04B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan